Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Cerevel Therapeutics Holdings Inc | 16.61% | 8.62bn |
ImmunoGen Inc | 21.73% | 10.22bn |
Data delayed at least 15 minutes, as of Jun 15 2024 00:00 BST.
0.00%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 29 Feb 2024 | 423.21k | 0.00% |
BB Gest�o de Recursos DTVM SAas of 29 Feb 2024 | 220.90k | 0.00% |
Bram Bradesco Asset Management S/A DTVMas of 29 Feb 2024 | 61.04k | 0.00% |
XP Allocation Asset Management Ltda.as of 29 Feb 2024 | 1.90k | 0.00% |
More ▼
Data from 29 Feb 2024 - 06 Jun 2024Source: FactSet Research Systems Inc.